CETYL ALCOHOL
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 242.0 | 5.5 | 1 | 1 | 20.0 | 14 | 1.0 |
- CAS
- 36653824
- UNII
- 936JST6JCN
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 65 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02124512 | 2014-12-01 | Blood Lipopolysaccharide (LPS) Rifaximin Study | Phase 2 | Not Yet Recruiting |
| NCT01904409 | 2013-06-01 | Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis | Phase 2 | Active, Not Recruiting |
| NCT00280228 | 2006-01-01 | Home Based Treatment for Drug Use in Early Adolescents | Phase 2 | Completed |
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Auricular (Otic) | Suspension | 1% |
| Ophthalmic | Suspension | 0.5% |
| Oral | Capsule, Delayed Release | 2.33MG |
| Oral | Capsule, Enteric Coated Pellets | 3.07MG |
| Oral | Tablet | |
| Oral | Tablet, Coated | 0.25MG |
| Oral | Tablet, Film Coated | |
| Oral | Tablet, Sustained Action | 44MG |
| Oral | Tablet, Sustained Action, Film Coated | 59MG |
| Rectal | Aerosol, Metered | 0.16% |
| Rectal | Emulsion, Aerosol Foam | 0.66% |
| Topical | Aerosol | 1.16% |
| Topical | Aerosol, Metered | |
| Topical | Cream, Augmented | 4% |
| Topical | Cream, Emulsion, Sustained Release | 6% |
| Topical | Emulsion, Aerosol Foam | 3.23% |
| Topical | Emulsion, Cream | 12% |
| Topical | Lotion | 4.5% |
| Topical | Ointment | 7% |
| Topical | Suppository | |
| Topical | Suppository, Insert | |
| Topical | Suspension | 2.01%W/W |
| Vaginal | Cream, Emulsion, Sustained Release | 5% |
| Vaginal | Emulsion, Aerosol Foam | 0.75% |
| Vaginal | Emulsion, Cream | 15% |